Managed care, hospice use, site of death, and medical expenditures in the last year of life
- PMID: 12153375
- DOI: 10.1001/archinte.162.15.1722
Managed care, hospice use, site of death, and medical expenditures in the last year of life
Abstract
Background: We examined deaths of Medicare beneficiaries in Massachusetts and California to evaluate the effect of managed care on the use of hospice and site of death and to determine how hospice affects the expenditures for the last year of life.
Methods: Medicare data for beneficiaries in Massachusetts (n = 37 933) and California (n = 27 685) who died in 1996 were merged with each state's death certificate files to determine site and cause of death. Expenditure data were Health Care Financing Administration payments and were divided into 30-day periods from the date of death back 12 months.
Results: In Massachusetts, only 7% of decedents were enrolled in managed care organizations (MCOs); in California, 28%. More than 60% of hospice users had cancer. Hospice use was much lower in Massachusetts than in California (12% vs 18%). In both states, decedents enrolled in MCOs used hospice care much more than those enrolled in fee-for-service plans (17% vs 11% in Massachusetts and 25% vs 15% in California). This pattern persisted for those with cancer and younger (aged 65-74 years) decedents. Decedents receiving hospice care were significantly (P<.001 for both) less likely to die in the hospital (11% vs 43% in Massachusetts and 5% vs 43% in California). Enrollment in MCOs did not affect the proportion of in-hospital deaths (those enrolled in fee-for-service plans vs MCOs: 40% vs 39% in Massachusetts; and 37% vs 34% in California). Expenditures in the last year of life were $28 588 in Massachusetts and $27 814 in California; about one third of the expenditures occurred in the last month before death. Hospital services accounted for more than 50% of all expenditures in both states, despite 77% of decedents being hospitalized in Massachusetts and just 55% being hospitalized in California. Among patients with cancer, expenditures were 13% to 20% lower for those in hospice.
Conclusions: Medicare-insured decedents in California were more than 4 times more likely to be enrolled in MCOs, were 50% more likely to use a hospice, and had a 30% lower hospitalization rate than decedents in Massachusetts, yet there are few differences in out-of-hospital deaths or expenditures in the last year of life. However, patients with cancer using hospice did have significant savings.
Similar articles
-
Influence of age on Medicare expenditures and medical care in the last year of life.JAMA. 2001 Sep 19;286(11):1349-55. doi: 10.1001/jama.286.11.1349. JAMA. 2001. PMID: 11560540
-
Medicare program expenditures associated with hospice use.Ann Intern Med. 2004 Feb 17;140(4):269-77. doi: 10.7326/0003-4819-140-4-200402170-00009. Ann Intern Med. 2004. PMID: 14970150
-
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.Health Serv Res. 2004 Apr;39(2):363-75. doi: 10.1111/j.1475-6773.2004.00232.x. Health Serv Res. 2004. PMID: 15032959 Free PMC article.
-
Cost of dementia in Medicare managed care: a systematic literature review.Am J Manag Care. 2019 Aug 1;25(8):e247-e253. Am J Manag Care. 2019. PMID: 31419102 Free PMC article.
-
Symptom character and prevalence during cancer patients' last days of life.Am J Hosp Palliat Care. 1991 Mar-Apr;8(2):6-8, 18. doi: 10.1177/104990919100800208. Am J Hosp Palliat Care. 1991. PMID: 1931318 Review. No abstract available.
Cited by
-
A Patient-Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End-of-Life Discussions and Reduce Unwanted Health Care Costs.Oncologist. 2019 Jan;24(1):76-85. doi: 10.1634/theoncologist.2018-0238. Epub 2018 Sep 28. Oncologist. 2019. PMID: 30266893 Free PMC article.
-
Spouses' effectiveness as end-of-life health care surrogates: accuracy, uncertainty, and errors of overtreatment or undertreatment.Gerontologist. 2008 Dec;48(6):811-9. doi: 10.1093/geront/48.6.811. Gerontologist. 2008. PMID: 19139254 Free PMC article.
-
Cost effectiveness analysis of a hypertension management program in patients with type 2 diabetes.J Clin Hypertens (Greenwich). 2009 Mar;11(3):116-24. doi: 10.1111/j.1751-7176.2009.00082.x. J Clin Hypertens (Greenwich). 2009. PMID: 19302422 Free PMC article.
-
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.Ann Oncol. 2010 May;21(5):1072-7. doi: 10.1093/annonc/mdp405. Epub 2009 Oct 15. Ann Oncol. 2010. PMID: 19833820 Free PMC article.
-
Support of cancer patients' spiritual needs and associations with medical care costs at the end of life.Cancer. 2011 Dec 1;117(23):5383-91. doi: 10.1002/cncr.26221. Epub 2011 May 11. Cancer. 2011. PMID: 21563177 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical